Biotechnology

Global Cord Blood Corporation Provides Update on Impact of Coronavirus

HONG KONG, Feb. 14, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 2019 ...

2020-02-14 19:30 12939

Eirgenix Receives Approval from Japan's PMDA

TAIPEI, Feb. 14, 2020 /PRNewswire/ -- EirGenix, Inc. (6589, TT) had undertaken the transfer of drug substance manufacturing of a marketed drug from a Japanese pharmaceutical company and has since fulfilled all the regulatory requirements necessary to complete the manufacturing site transfer. The ...

2020-02-14 15:14 2781

Sihuan Pharmaceutical Accelerates Product Expansion in Digestive System and Liver Related Diseases

HONG KONG, Feb. 14, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd.(HKEX: 0460) ("Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the progress achieved by the Group in the research and development of drugs for treati...

2020-02-14 10:35 7458

George Clinical Names James Cheong Chief Executive Officer

SYDNEY, Feb. 13, 2020 /PRNewswire/ -- George Clinical, a global scientifically-backed clinical research organization, has namedJames Cheong to the role of Chief Executive Officer. Cheong was hired as Chief Operating Officer at the beginning of 2019 and has overseen substantial growth of the bu...

2020-02-13 01:00 1809

Sirtex Medical announces collaboration with MIM Software Inc.

Partnership advances innovation and increases precision of liver-directed oncology therapies for patients WOBURN, Massachusetts, Feb. 12, 2020 /PRNewswire/ -- Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced a collaboration with MIM Software Inc., a lead...

2020-02-12 22:00 1668

IONpath Launches Research Services Offering Multiplexed Tissue Analysis to Empower Pharmaceutical Discovery and Development Programs

MENLO PARK, California, Feb. 12, 2020 /PRNewswire/ -- IONpath, Inc., today announces the launch of a dedicated service business providing access to their proprietary MIBIscope™ multiplexed imaging platform and its team of experts to support pharmaceutical and biotechnology companies working in im...

2020-02-12 03:25 2257

Genomenon Commended by Frost & Sullivan for Advancing Clinical Genomics Interpretation and Personalized Medicine with Its Mastermind Platform

The company's content-rich genomic database platform and AI-driven processing help mitigate early-stage genomic translational research challenges SANTA CLARA, California, Feb. 11, 2020 /PRNewswire/ -- Based on its recent analysis of the global clinical genomics interpretation market, Frost & Sul...

2020-02-11 22:00 1291

Carbiotix Launches Second Generation Diagnostic Platform

STOCKHOLM, Feb. 11, 2020 /PRNewswire/ -- Carbiotix (publ) ("Carbiotix") announces today that the company has launched its second generation diagnostic platform for gut health based on Next Generation Sequencing (NGS). The company will now offer a NGS test with three samples as a standard and at a...

2020-02-11 16:11 835

Medicines that Treat High Prevalence Conditions Offer Hope to Many as the Annual Drugs to Watch List from Clarivate Identifies 11 New Blockbusters Forecasted to Launch in 2020

PHILADELPHIA and LONDON, Feb. 10, 2020 /PRNewswire/ -- Clarivate Analytics plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced  the launch of its annual Cortellis "Drugs to Watch " list, which identifies 11 new...

2020-02-10 21:42 5087

Nanoform Establishes US Subsidiary

HELSINKI, Feb. 10, 2020 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, has established NanoformUSA Inc., a wholly owned subsidiary in the US. This is a natural progression for the company as it continues to increase the impact of its award-winning nanonization™ te...

2020-02-10 15:26 840

Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director

HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...

2020-02-06 19:30 12672

French Biotech TargEDys® Announces Positive Results of Its Clinical Trial With Its Probiotic Strain Hafnia alvei HA4597™ on the Weight Loss Thanks to Regulation of Appetite

PARIS, Feb. 6, 2020 /PRNewswire/ -- TargEDys® announces the successful completion of its 3 months, randomized, double blind, placebo-controlled, multicentric clinical study carried out on 229 subjects and evaluating the efficacy ofHafnia alvei HA4597™ in the weight loss by regulation of the appe...

2020-02-06 09:07 2340

Breakthrough Study Makes Cancer Detection Possible With a Simple Blood Test; Introduces a New Systemic Hallmark of Cancer

MUMBAI, India, Feb. 6, 2020 /PRNewswire/ -- A new study  by scientists from India, USA, and UK has presented clinical evidence for an innovative test that can detect clusters of cancer cells in the blood of asymptomatic individuals as a...

2020-02-06 08:00 2361

Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections

PLYMOUTH MEETING, Pennsylvania, Feb. 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 (HPV 6) for the treatment of recurrent respiratory pap...

2020-02-03 21:00 2431

GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma

- Belantamab mafodotin accepted for accelerated assessment by the EMA's Committee for Human Medicinal Products (CHMP) - Submission based on data from the pivotal DREAMM-2 study of immunoconjugate targeting B-cell maturation antigen (BCMA) recently published inThe Lancet Oncology LONDON, Feb. 3,...

2020-02-03 17:00 9177

Oxford Nanopore Sequencers Have Left UK for China, to Support Rapid, Near-sample Coronavirus Sequencing for Outbreak Surveillance

OXFORD, England, Feb. 3, 2020 /PRNewswire/ -- Following extensive support of, and collaboration with, public health professionals inChina, Oxford Nanopore has shipped an additional 200 MinION sequencers and related consumables toChina . These will be used to support the ongoing surveillance of the...

2020-02-03 05:20 2640

Coronavirus: New Gear Offers Protection For Patients And Healthcare Workers

MIAMI, Jan. 31, 2020 /PRNewswire/ -- In the ongoing war against Coronavirus, a new technology can provide much-needed protection and benefits for patients and healthcare workers.Radiation Shield Technologies' Demron Chemical Biological Radiological and Nuclear suits have patented thermal conducti...

2020-01-31 07:02 2216

Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China

Agreement will facilitate clinical trial translations in China PLYMOUTH MEETING, Pa., Jan. 30, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development inChina of INO-4800, Inovio'...

2020-01-30 19:00 4199

Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell's Gene Editing Platform and Oncology Product Portfolio

CAMBRIDGE, England and MILPITAS, Calif., Jan. 30, 2020 /PRNewswire/ -- Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce the asset purchase of the gene editing platform and oncology product portfolio of Applied StemCell, Inc. (ASC) for life science res...

2020-01-30 15:00 1173

MiRXES collaborates with NUS and DxD Hub to move Singapore to the forefront of global microRNA research and application

SINGAPORE, Jan. 29, 2020 /PRNewswire/ -- MiRXES, a leading Singaporean biotech start-up in microRNA[1] (miRNA) technology and diagnostics, collaborated with NUS and DxD Hub to mark the tenth year of miRNA research and clinical translation inSingapore. These organizations jointly led a non-coding ...

2020-01-29 10:00 2065